Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1948 1
1950 2
1951 1
1953 3
1954 1
1955 1
1956 2
1957 2
1958 2
1959 1
1960 1
1961 2
1962 1
1963 10
1964 6
1965 1
1968 1
1971 1
1972 1
1975 2
1979 1
1980 1
1981 2
1982 5
1983 6
1984 3
1985 2
1986 10
1987 7
1988 16
1989 17
1990 24
1991 26
1992 46
1993 41
1994 40
1995 44
1996 60
1997 77
1998 98
1999 114
2000 558
2001 184
2002 222
2003 298
2004 337
2005 383
2006 478
2007 484
2008 527
2009 548
2010 627
2011 665
2012 692
2013 962
2014 1586
2015 1923
2016 2140
2017 2387
2018 2676
2019 2848
2020 3495
2021 3802
2022 3869
2023 3722
2024 1667

Text availability

Article attribute

Article type

Publication date

Search Results

32,959 results

Results by year

Filters applied: . Clear all
Page 1
Chromogranin A in cardiovascular endocrinology.
Goetze JP, Hilsted LM, Rehfeld JF. Goetze JP, et al. Acta Physiol (Oxf). 2021 Apr;231(4):e13615. doi: 10.1111/apha.13615. Epub 2021 Jan 31. Acta Physiol (Oxf). 2021. PMID: 33460488 No abstract available.
Editorial: Insights in cardiovascular endocrinology: 2023.
Santulli G. Santulli G. Front Endocrinol (Lausanne). 2023 Aug 4;14:1266221. doi: 10.3389/fendo.2023.1266221. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 37600701 Free PMC article. No abstract available.
Cardiovascular endocrinology: introduction.
Baxter JD, Young WF Jr, Webb P. Baxter JD, et al. Endocr Rev. 2003 Jun;24(3):253-60. doi: 10.1210/er.2003-0099. Endocr Rev. 2003. PMID: 12788796 Review. No abstract available.
Cardiovascular Endocrinology & Metabolism.
Krentz AJ. Krentz AJ. Cardiovasc Endocrinol Metab. 2018 Feb 14;7(1):1. doi: 10.1097/XCE.0000000000000149. eCollection 2018 Mar. Cardiovasc Endocrinol Metab. 2018. PMID: 31646269 Free PMC article. No abstract available.
Editorial: Rising stars in cardiovascular endocrinology 2022.
Lorenzo Ó. Lorenzo Ó. Front Endocrinol (Lausanne). 2023 Mar 13;14:1175403. doi: 10.3389/fendo.2023.1175403. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 36992804 Free PMC article. No abstract available.
Heart failure in diabetes.
Jankauskas SS, Kansakar U, Varzideh F, Wilson S, Mone P, Lombardi A, Gambardella J, Santulli G. Jankauskas SS, et al. Metabolism. 2021 Dec;125:154910. doi: 10.1016/j.metabol.2021.154910. Epub 2021 Oct 8. Metabolism. 2021. PMID: 34627874 Free PMC article. Review.
Heart failure and cardiovascular disorders represent the leading cause of death in diabetic patients. ...
Heart failure and cardiovascular disorders represent the leading cause of death in diabetic patients. ...
Dyslipidemia in Chronic Kidney Disease.
Rosenstein K, Tannock LR. Rosenstein K, et al. 2022 Feb 10. In: Feingold KR, Anawalt B, Blackman MR, Boyce A, Chrousos G, Corpas E, de Herder WW, Dhatariya K, Dungan K, Hofland J, Kalra S, Kaltsas G, Kapoor N, Koch C, Kopp P, Korbonits M, Kovacs CS, Kuohung W, Laferrère B, Levy M, McGee EA, McLachlan R, New M, Purnell J, Sahay R, Shah AS, Singer F, Sperling MA, Stratakis CA, Trence DL, Wilson DP, editors. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; 2000–. 2022 Feb 10. In: Feingold KR, Anawalt B, Blackman MR, Boyce A, Chrousos G, Corpas E, de Herder WW, Dhatariya K, Dungan K, Hofland J, Kalra S, Kaltsas G, Kapoor N, Koch C, Kopp P, Korbonits M, Kovacs CS, Kuohung W, Laferrère B, Levy M, McGee EA, McLachlan R, New M, Purnell J, Sahay R, Shah AS, Singer F, Sperling MA, Stratakis CA, Trence DL, Wilson DP, editors. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; 2000–. PMID: 26247091 Free Books & Documents. Review.
Thus, therapies to reduce cardiovascular risk are urgently needed in CKD. Robust clinical trial evidence has found that use of statins in pre-end stage CKD patients, as well as in renal transplant recipients, can decrease cardiovascular events; however, providers ne …
Thus, therapies to reduce cardiovascular risk are urgently needed in CKD. Robust clinical trial evidence has found that use of statin …
32,959 results
You have reached the last available page of results. Please see the User Guide for more information.